Literature DB >> 28325505

Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.

Karen E Moeller1, Julie C Kissack2, Rabia S Atayee3, Kelly C Lee3.   

Abstract

Urine drug testing is frequently used in clinical, employment, educational, and legal settings and misinterpretation of test results can result in significant adverse consequences for the individual who is being tested. Advances in drug testing technology combined with a rise in the number of novel misused substances present challenges to clinicians to appropriately interpret urine drug test results. Authors searched PubMed and Google Scholar to identify published literature written in English between 1946 and 2016, using urine drug test, screen, false-positive, false-negative, abuse, and individual drugs of abuse as key words. Cited references were also used to identify the relevant literature. In this report, we review technical information related to detection methods of urine drug tests that are commonly used and provide an overview of false-positive/false-negative data for commonly misused substances in the following categories: cannabinoids, central nervous system (CNS) depressants, CNS stimulants, hallucinogens, designer drugs, and herbal drugs of abuse. We also present brief discussions of alcohol and tricyclic antidepressants as related to urine drug tests, for completeness. The goal of this review was to provide a useful tool for clinicians when interpreting urine drug test results and making appropriate clinical decisions on the basis of the information presented.
Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28325505     DOI: 10.1016/j.mayocp.2016.12.007

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  False-positive phencyclidine (PCP) on urine drug screen attributed to desvenlafaxine (Pristiq) use.

Authors:  T Michael Farley; Emily N Anderson; Jade N Feller
Journal:  BMJ Case Rep       Date:  2017-11-23

2.  Large Variation in Provincial Guidelines for Urine Drug Screening during Opioid Agonist Treatment in Canada.

Authors:  Eloise Moss; Jasmine McEachern; Lauren Adye-White; Kelsey C Priest; Lauren Gorfinkel; Evan Wood; Walter Cullen; Jan Klimas
Journal:  Can J Addict       Date:  2018-06

3.  Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.

Authors:  Weize Huang; Lindsay C Czuba; Nina Isoherranen
Journal:  J Pharmacol Exp Ther       Date:  2020-03-20       Impact factor: 4.030

4.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

5.  Health effects from unintentional occupational exposure to opioids among law enforcement officers: Two case investigations.

Authors:  Sophia K Chiu; Jennifer L Hornsby-Myers; Marie A de Perio; John E Snawder; Douglas M Wiegand; Douglas Trout; John Howard
Journal:  Am J Ind Med       Date:  2019-04-23       Impact factor: 2.214

6.  Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis.

Authors:  M Eugenia Socías; JinCheol Choi; Stephanie Lake; Evan Wood; Jenna Valleriani; Kanna Hayashi; Thomas Kerr; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-12-17       Impact factor: 4.492

7.  A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation.

Authors:  Miriam Harris; Kathleen Joseph; Bettina Hoeppner; Elisha M Wachman; Jessica R Gray; Kelley Saia; Sarah Wakeman; Megan H Bair-Merritt; Davida M Schiff
Journal:  J Addict Med       Date:  2021 Jul-Aug 01       Impact factor: 3.702

8.  The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada.

Authors:  M Eugenia Socias; Cameron Grant; Kanna Hayashi; Geoff Bardwell; Mary Clare Kennedy; M-J Milloy; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2021-09-25       Impact factor: 4.492

9.  Identifying Prevalence of and Risk Factors for Abnormal Urine Drug Tests in Cancer Pain Patients.

Authors:  Kelly E Leap; Grant H Chen; Jasme Lee; Kay See Tan; Vivek Malhotra
Journal:  J Pain Symptom Manage       Date:  2020-12-01       Impact factor: 5.576

10.  THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults.

Authors:  Ryan P Cabeen; John M Allman; Arthur W Toga
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.